Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

QLT (Rights to Aczone)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Distribution rights of a drug. The asset gel product is used for the treatment of acne vulgaris in patients 12 years and older.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Business Products and Services
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 887 Great Northern Way
  • Suite 250
  • Vancouver, British Columbia V5T 4T5
  • Canada

QLT (Rights to Aczone) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore QLT (Rights to Aczone)‘s full profile, request access.

Request full access to PitchBook

QLT (Rights to Aczone) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore QLT (Rights to Aczone)‘s full profile, request access.

Request full access to PitchBook